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Abstract
Background: The vast amounts of clinical data collected in electronic health records (EHR) is analogous to the data
explosion from the ‘‘-omics’’ revolution. In the EHR clinicians often maintain patient-specific problem summary lists which
are used to provide a concise overview of significant medical diagnoses. We hypothesized that by tapping into the
collective wisdom generated by hundreds of physicians entering problems into the EHR we could detect significant
associations among diagnoses that are not described in the literature.
Methodology/Principal Findings: We employed an analytic approach original developed for detecting associations
between sets of gene expression data, called Molecular Concept Map (MCM), to find significant associations among the 1.5
million clinical problem summary list entries in 327,000 patients from our institution’s EHR. An odds ratio (OR) and p-value
was calculated for each association. A subset of the 750,000 associations found were explored using the MCM tool.
Expected associations were confirmed and recently reported but poorly known associations were uncovered. Novel
associations which may warrant further exploration were also found. Examples of expected associations included non-
insulin dependent diabetes mellitus and various diagnoses such as retinopathy, hypertension, and coronary artery disease.
A recently reported association included irritable bowel and vulvodynia (OR 2.9, p=5.6610
24). Associations that are
currently unknown or very poorly known included those between granuloma annulare and osteoarthritis (OR 4.3,
p=1.1610
24) and pyloric stenosis and ventricular septal defect (OR 12.1, p=2.0610
23).
Conclusions/Significance: Computer programs developed for analyses of ‘‘-omic’’ data can be successfully applied to the
area of clinical medicine. The results of the analysis may be useful for hypothesis generation as well as supporting clinical
care by reminding clinicians of likely problems associated with a patient’s existing problems.
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Introduction
The implementation of electronic health records (EHR) at our
institution and peer institutions has allowed for the storage of vast
amounts of information in clinical data repositories. The EHR
allows clinicians to maintain a problem summary list (PSL) for
each patient which is used in clinical medicine to provide a concise
overview of the significant medical issues and diagnoses. Clinicians
are free to add whatever problems are deemed appropriate,
including both chronic and acute conditions. Like much of the
data in the EHR, the items in our PSL are free text, resulting in
marked variability. While the PSL is meant primarily for
diagnoses, clinicians also often add signs (e.g., fever, tachypnea,
pallor) and symptoms (e.g., fatigue, back pain, cough). This has
made large-scale analyses and mining of the data a challenge.
Nevertheless, with over 10 years of clinical data in our EHR, we
hypothesized that harnessing the power of the roughly 2,000
clinicians in our health system who enter diagnoses in the PSL
could help bring to light interesting associations that are either
poorly known or unknown. Studies seeking associations among
diagnoses in EHRs have been explored in the past, although they
have often focused on specific diseases[1,2] or used coded
concepts. [3] One prior study extracted diseases and findings
from patient documents using natural language processing to look
for associations.[4]
The advent of the ‘‘-omics’’ revolution has led to the
development of many software packages for analyzing gene
expression data, including a locally developed tool, the Molecular
Concept Map (MCM).[5] The MCM application was originally
developed to perform analyses of gene expression data to find
significant associations among gene expression signatures. MCM
also has the ability to construct network graphs of associations
which allows for visualization of the relationship to help answer
why two concepts may be associated. Another analogous approach
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5203is gene set enrichment analysis developed by the Broad
Institute.[6,7] Fortunately, MCM is flexible enough to accommo-
date other data types including free text clinical data, making it an
ideal platform for exploratory studies using data from the EHR.
Methods
To test our hypothesis we chose to use an unbiased approach to
look for co-occurrences among all entries in the PSL. We
combined the automated processes supported by the MCM
application with manual human interpretation of the results.
After receiving approval from our institutional review board we
obtained 1.5 million free text problem summary list diagnoses for
approximately 327,000 patients in our clinical data repository. A
total of 20,705 unique free text diagnoses that each appeared in at
least 5 patients were included. Some of the most common
diagnoses included ‘‘hypertension’’, ‘‘infection’’, ‘‘depression’’,
‘‘asthma’’, ‘‘otitis media’’, and ‘‘diabetes’’, with 58,110, 31,044,
29,025, 28,864, 27,863, and 27,410 instances of each, respectively.
The MCM application was capable of automatically mapping
smaller terms that were subsets of larger ones (e.g., ‘‘type 2
diabetes’’ into ‘‘type 2 diabetes mellitus’’). Due to the variability in
the wording of the free text diagnoses, we manually reviewed the
3,500 most common terms in our list of 20,705. For terms that
were abbreviated, we manually mapped them to one another so
that, for example ‘‘T2DM’’ was made equivalent to ‘‘type 2
diabetes mellitus’’. We stopped manual mapping after 3,500 terms
because most terms at that point were considered unique or
already mapped to another term. Of these 3,500 most common
terms we mapped 330 common diagnoses, some of which were
actually variations of the same concept (e.g., ‘‘GIB’’=‘‘GI
bleed’’=‘‘gastrointestinal bleed’’).
These data were then loaded into the MCM application for
further analysis. Each patient and his or her associated diagnoses
was considered to be equivalent to a gene expression signature.
Pairwise associations were computed across all clinical problems
from the PSL. Odds ratios (ORs) and p-values were calculated for
each association.
We then used the graphical user interface of MCM to search for
both common and unusual associations. Common associations
were sought to provide internal validity to the findings of the
system, since we expected that well-known associations would be
uncovered. This process was performed manually by typing a
diagnosis into MCM and then reviewing the significantly
associated diagnoses discovered by the system. We also looked
for unknown, or poorly known, associations and then sought
confirmation for these associations in the literature with a PubMed
search. No comprehensive database of all known clinical
associations is available for comparison, which is why our process
of validation and data exploration was manual.
Results and Discussion
We explored numerous associations among diagnoses in our
electronic medical record using the Molecular Concept Maps
(MCM) web application. The analysis uncovered 753,574
Figure 1. Overall network diagram containing 1106 nodes and 1939 edges showing the most significant problem category
associations using an odds ratio.100.0 and p-value,1.0610
210 as thresholds for inclusion. Nodes are roughly proportional to the
number of times each problem appears in the problem summary list (PSL) and only nodes with more than 100 occurrences are shown. Problems are
color-coded based on the general area in medicine in which the problem would likely be diagnosed or followed. At this level several clusters of
related problems can be seen, some of which are labeled above.
doi:10.1371/journal.pone.0005203.g001
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had an odds ratio greater than 3.0 and a p-value less than
1.0610
23. These associations represented just 0.2% of the possible
pairs based on the original list of 20,705 problems. A network
graph with the strongest associations is shown in Figure 1. Clusters
of diagnoses within similar medical categories can be seen in this
high-level view.
Many of the associations we found were already well known;
selecting those which were noteworthy for exploration required a
background in clinical medicine. The associations in Figure 2 are
generally well known and provided us with validation that the tool
adequately discovered significant and expected associations. This
is true for both the common diagnosis of non-insulin dependent
diabetes mellitus (type 2 diabetes) as well as the less common
diagnosis of Turner syndrome. Diagnoses associated with Turner
syndrome included frequently described defects such as coarcta-
tion of the aorta (OR 140.0, p=6.4610
210), horseshoe kidney
(OR 322.5, p=1.1610
211), and ovarian failure (OR 155.1,
p=1.4610
26).[8] Several more well known associations are
shown in Table 1.
We used the MCM network graphs to identify unexpected
associations and form hypotheses about why such associations
might exist. Significant associations with the diagnosis of
‘‘vulvodynia’’ are shown in Figure 3A. While most of the
associations in the network are related to gynecology, which
would be expected, both ‘‘irritable bowel’’ (OR 2.9,
p=5.6610
24), and ‘‘fibromyalgia’’ (OR 5.0, p=2.5610
25) are
not. Two recent articles by Arnold et al reported associations
between vulvodynia and both irritable bowel (ORs 1.86 and 3.11)
and fibromyalgia (ORs 2.15 and 3.84 ).[9,10] This compares
reasonably well with our findings in MCM.
More associations with recent literature support are in Table 2
and show that MCM revealed associations that have recently been
reported. Some of these may be indirect associations. For example,
‘‘von Willebrands disease’’ and ‘‘seizure’’ (OR 5.8, p=3.4610
24)
are likely related because a common medication to treat seizures,
Figure 2. Network graphs showing well-known clinical associations. Node size represents the approximate number of diagnoses in the
database and edges represent significant associations between nodes. Node colors are designated according to the legend in Figure 1. 2A displays
the complex network of associations linked to the diagnosis of ‘‘noninsulin dependent diabetes mellitus’’ (type 2 diabetes mellitus) using an odds
ratio of 1.25 or greater. While the network is mostly interconnected, ‘‘cataracts’’ are not directly associated with either ‘‘obesity’’ or ‘‘sleep apnea’’. 2B
displays the same diagnoses associated with NIDDM using an odds ratio of 8.0 or more as a threshold for connections between nodes. At this odds
ratio less significant associations drop out and stronger ones persist. 2C shows common associations with the diagnosis ‘‘Turner syndrome’’ using an
odds ratio of 1.25 or greater. ‘‘Horsehoe kidney’’ and ‘‘ovarian failure’’ are independently associated with Turner syndrome, whereas the cardiac
defects are associated with one another. Coarctation appears twice because of the free text variability of the diagnoses.
doi:10.1371/journal.pone.0005203.g002
Table 1. Well-known associations among problems in the
PSL, including supporting literature.
Problem
Associated
problem P value
Odds
ratio
Supporting
Literature
(PubMedID)
Low back pain Insomnia 7.9610
277 4.5 15033151
Henoch Schonlein
purpura
Intussusception 1.8610
216 213.4 18351468
Primary sclerosing
cholangitis
Ulcerative colitis 1.0610
2100 229 18200656
Developmental delay Phenylketonuria 8.5610
25 41.0 16763886
Secondary
hyperparathyroidism
Anemia 1.0610
2100 49.6 18496265
Problems in the first column were selected in the MCM application and
noteworthy associated problems were explored, reported in the second
column.
doi:10.1371/journal.pone.0005203.t001
Figure 3. Examples of network graphs used to help identify
unexpected associations and form hypotheses about the
meaning of the associations. Figure 3A shows a network graph
with selected associations for the diagnosis ‘‘vulvodynia’’ using a
threshold for edges as odds ratio of 2.5 or more and p-value of
1.0610
23 or less. ‘‘Fibromyalgia’’ and ‘‘irritable bowel’’ are associated
with ‘‘vulvodynia’’ independently from the other inter-related gyneco-
logic diagnoses. Figure 3B displays a network graph showing the
associations between ‘‘shingles’’, ‘‘hypothyroidism’’, and other cancer-
related diagnoses, using a threshold for edges as odds ratio of 1.75 or
more and p value of 1.0610
24 or less. Use of such a network helps to
determine that the relationship between ‘‘shingles’’ and ‘‘hypothyroid-
ism’’ may be due to cancer therapies. Node size represents the
approximate number of diagnoses in the database. Node colors are
designated according to the legend in Figure 1.
doi:10.1371/journal.pone.0005203.g003
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disease.[11] Likewise, it is possible that ‘‘guillain barre syndrome’’
is associated with ‘‘end stage renal disease’’ (OR 20.3,
p=6.5610
25) because a common treatment of severe Guillain-
Barre ´ syndrome is intravenous immunoglobulins which itself can
cause renal failure.[12]
Use of the network graph to reveal plausible explanations for
unexpected associations is demonstrated in Figure 3B. When an
association between ‘‘hypothyroidism’’ and ‘‘shingles’’ (OR 2.9,
p=6.2610
212) was first noted, a reasonable explanation could not
be found. However, adding other significantly associated elements
into the network graph provided the likely scenario that both were
related to one another as a side effect of chemotherapy or other
anti-neoplastic therapies for both breast and colon cancer.
Other unusual associations for which an explanation likely exists
are shown in Table 3. The association between ‘‘gilberts disease’’
and ‘‘family history of colon cancer’’ (OR 26.5, p=2.5610
24)
likely exists due to a cancer trial protocol at our institution asking
clinicians to monitor bilirubin levels but has exceptions for patients
with Gilberts. Thus, the association may simply be a reflection of
increased vigilance for Gilberts in patients who have colon cancer.
‘‘Tricuspid regurgitation’’ may be strongly associated to ‘‘past use
of tobacco’’ (OR 155.0, p=1.0610
2100) because smoking can
cause chronic obstructive pulmonary disease with subsequent
development of cardiac disease. ‘‘Keloids’’ and ‘‘history of
asthma’’ (OR 17.4, p=1.1610
24) may have race as a common
link, as both conditions are known to occur frequently in African
Americans.[13,14] Finally, ‘‘colon cancer’’ and ‘‘osteopenia’’ (OR
3.9, p=3.3610
227) may also have a logical explanation. Calcium
is thought to prevent adenomas, which can later become colon
cancer.[15] Therefore, low calcium may predispose patients to
colon cancer, and osteopenia may be a proxy for low calcium
levels. Alternatively, ostepenia may also be a side effect of various
cancer treatments including chemotherapy and radiation, or from
the cancer itself.[16] Knowing the temporal sequence of when the
diagnoses were first noted could help point to the cause.
Selected problems for which we do not know of a previously
reported association are presented in Table 4. The association
Table 2. Recently reported associations with support from the literature.
Problem Associated problem P value Odds ratio
Supporting Literature
(PubMedID)
Amyotrophic lateral sclerosis History of smoking 8.6610
222 101.4 15229114, 10364720
Menieres disease Hypothyroidism 7.4610
212 4.1 14967756
Intussusception Herpangina 2.4610
24 26.6 10493041
Pituitary microadenoma Irritable bowel 4.7610
24 5.5 16472586
Hypothyroidism Fibromyalgia 7.5610
280 3.8 17102943, 15468372
Migraine headaches Depression 1.4610
2100 3.6 16483117
Acute appendicitis Nicotine addiction 4.4610
24 8.2 9950450
Migraine headaches Asthma 2.5610
272 2.2 12236275
Peyronie’s disease Alcoholism 8.0610
23 7.6 16469028
Conduct disorder Strep 1.5610
26 7.9 11929370, 12880661
Vulvodynia Fibromyalgia 2.5610
25 5.0 17306651
Vulvodynia Irritable bowel 5.6610
24 2.9 17306651
Vulvodynia Candidiasis 8.0610
213 19.2 17306651
Carpal tunnel syndrome Osteoarthritis 1.2610
2100 5.9 12928223
Carpal tunnel syndrome Diabetes 1.3610
248 2.7 12928223
Carpal tunnel syndrome Hypothyroidism 4.7610
248 3.1 12928223
Carpal tunnel syndrome Rheumatoid arthritis 6.2610
227 4.5 12928223
Gout Cardiomyopathy 1.0610
2100 10.5 2256745, 10232447
Tourette syndrome Migraines 5.0610
23 4.7 14623732
Lyme disease Depression 4.8610
27 3.79 7943444, 10918770
Diabetes Tobacco 2.6610
256 1.9 16603565
Schizophrenia Diabetes 3.0610
213 2.0 15056604
Von willebrands disease Seizure 3.4610
24 5.8 11913569
Guillain Barre syndrome End stage renal disease 6.5610
25 20.3 9761533, 9170022
doi:10.1371/journal.pone.0005203.t002
Table 3. Associations that are unknown or poorly known but
may have an explanation.
Problem
Associated
problem P value
Odds
ratio
Shingles Hypothyroidism 6.2610
212 2.9
Gilberts disease Family History of
colon cancer
2.5610
24 26.5
Keloids History of asthma 1.1610
24 17.4
Tricuspid regurgitation Past use of tobacco 1.0610
2100 155.0
Colon Cancer Osteopenia 3.3610
227 3.9
doi:10.1371/journal.pone.0005203.t003
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p=1.1610
24) is interesting since both can be treated with
niacin,[17,18] suggesting that a common underlying pathway
might exist. Likewise, the association between ‘‘pyloric stenosis’’
and ‘‘ventricular septal defect’’ (OR 12.1, p=2.0610
23)i s
unknown although both are disorders of muscle tissue. Whether
or not this suggests a common underlying mechanism is unknown.
The associations with ‘‘shatskis ring’’ are also unusual but may be
a result of inadvertent findings as a result of radiologic studies.
This study does have several limitations. Discovering an
association does not imply causation and we did not take into
accountthetemporalsequenceofthediagnoses.Additionally,simply
because an association exists between two diagnoses does not imply
medical relevance, nor does it imply that the association is valid.
Others who have done similar studies used a threshold for finding
relevant associations since some of the weaker ones may simply be
due to chance given the large number of comparisons being
made.[19] We chose not to ignore less significant associations but
rather used our clinical judgment when reviewing them. It may be
the case that less significant, but nevertheless real, associations have
been overlooked with prior methodologies.
All diagnoses were entered at the discretion of the clinicians in
our health system. We do not know if diagnoses were made using
strict definitions or classification criteria (e.g., diagnosing a
migraine headache when it may really be a tension headache, or
diagnosing lupus without use of the 11 criteria). It has been shown
that coded diagnoses from billing data can often be extremely
inaccurate [20] so it is possible that the diagnoses in our PSL,
which are not used for billing purposes, were also inaccurate.
Clinicians may also fail to enter all of a patient’s problems, which
has been reported elsewhere.[21]
The free text nature of the diagnoses in our system also made
finding significant associations challenging because some concepts
may have been worded differently and not mapped to a single
concept. As a result, they would have been considered to be
completely different diagnoses by the system. Nevertheless, the
large volume of problems did allow us to find significant
associations even with the limitation of using free text.
Use of the MCM tool could be useful for hypothesis generation,
and the confirmation in recent literature of multiple associations
that we found supports this assertion. Further work in the
laboratory to elucidate possible mechanisms could confirm the
validity of this approach, especially where preliminary reports
suggest a common pathway such as the use of niacin to treat both
granuloma annulare and osteoarthritis.
We also believe that the significant associations generated could
support clinical activities as well. Such a knowledge base could
provide a form of clinical decision support to ensure that related
diagnoses are not missed, or even to support the entry into the PSL
of related problems that a clinician may not have thought to enter
into the EHR. Furthermore, the knowledge base could be
continually and automatically updated as more data are entered
into the PSL by clinicians.
It might be possible, for example, that if someone were to enter
‘‘low back pain’’ as a diagnosis (see Table 1) that such a system
could prompt the clinician to also ask about problems with
‘‘insomnia’’ since the association was strong. Insomnia may be a
result of both the suffering one endures from chronic back pain as
well as from possible treatments for back pain [22,23] but it would
be important for a clinician to consider the possibility of a sleep
disorder in someone with back pain.
Future work with this tool could involve implementing in a
clinical care setting a system loaded with the associations to
provide real-time suggestions to clinicians to determine the utility
of the suggestions. We also believe that comparing our results with
those of other institutions would help to support or refute some of
the more unusual findings uncovered in our analysis. Furthermore,
combining clinical diseases with laboratory findings, such as what
was done with the Human Disease Network,[24] could further
help uncover and elucidate novel associations.
Table 4. Associations that are unknown or poorly known.
Problem Associated problem P value Odds ratio
Granuloma Annulare Osteoarthritis 1.1610
24 4.3
Granuloma Annulare Fibromyalgia 1.0610
23 6.9
Pyloric Stenosis Ventricular Septal Defect 2.0610
23 12.1
Anosmia Varicella 1.7610
218 46.3
Diverticular disease Hypothyroidism 1.6610
27 5.4
Attention Deficit Hyperactivity Disorder Osgood Schlatter disease 1.1610
26 11.5
Irregular Periods Bipolar disorder 2.0610
23 8.4
Schatzkis ring Spinal stenosis 4.3610
25 22.3
Schatzkis ring Diverticulosis 9.8610
29 17.1
Schatzki ring Nephrolithiasis 3.1610
25 11.0
Irritable bowel syndrome Plantar fasciitis 8.0610
216 3.5
Breast calcifications Agoraphobia 8.6610
26 83.7
Thyromegaly Varicella 8.4610
26 13.6
Fuchs dystrophy Hypothyroid 1.6610
28 19.8
Cat bite Depression 1.7610
25 3.0
Ankylosing spondylitis TURP 1.4610
25 29.4
Spondylolisthesis Hepatitis A 3.6610
25 23.0
Dacryostenosis Jaundice 1.6610
255 44.4
doi:10.1371/journal.pone.0005203.t004
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